Literature DB >> 19700319

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids.

Javier de Vicente1, Robert T Hendricks, David B Smith, Jay B Fell, John Fischer, Stacey R Spencer, Peter J Stengel, Peter Mohr, John E Robinson, James F Blake, Ramona K Hilgenkamp, Calvin Yee, Junping Zhao, Todd R Elworthy, Jahari Tracy, Elbert Chin, Jim Li, Al Lui, Beihan Wang, Connie Oshiro, Seth F Harris, Manjiri Ghate, Vincent J P Leveque, Isabel Najera, Sophie Le Pogam, Sonal Rajyaguru, Gloria Ao-Ieong, Ludmila Alexandrova, Bill Fitch, Michael Brandl, Mohammad Masjedizadeh, Shao-Yong Wu, Steve de Keczer, Tatyana Voronin.   

Abstract

Benzothiazine-substituted tetramic acids were discovered as highly potent non-nucleoside inhibitors of HCV NS5B polymerase. X-ray crystallography studies confirmed the binding mode of these inhibitors with HCV NS5B polymerase. Rational optimization of time dependent inactivation of CYP 3A4 and clearance was accomplished by incorporation of electron-withdrawing groups to the benzothiazine core.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700319     DOI: 10.1016/j.bmcl.2009.08.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  2-(3-Oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetohydrazide.

Authors:  Azher Saeed; Zaid Mahmood; Shiyao Yang; Saeed Ahmad; Muhammad Salim
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

2.  Classification of HCV NS5B polymerase inhibitors using support vector machine.

Authors:  Maolin Wang; Kai Wang; Aixia Yan; Changyuan Yu
Journal:  Int J Mol Sci       Date:  2012-03-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.